Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial is a research paper published in Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: R37AI054165
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: UM1AI068635
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: 75A50120C00034
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: R01CA277133
NIAID NIH HHS
Grant: U01 AI068635
NIAID NIH HHS
Grant: UM1 AI069424
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
National Institutes of Health
Grant: 5R37AI054165-12
Statistical Methods in HIV Vaccine Efficacy Trials
National Institutes of Health
Grant: 5R01CA277133-02
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
European Commission
Grant: 277133
Atypical Works in Pre-Industrial Europe. Pluriactivity, Mobility and Social Identities
FWCI
3.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals